Humoral response in hemodialysis patients post-SARS-CoV-2 mRNA vaccination: a systematic review of literature

KI Notarte, JA Catahay, PJ Peligro, JV Velasco, AT Ver… - Vaccines, 2023 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has infected over 600 million individuals and caused …

Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis

S Xu, J Li, H Wang, F Wang, Z Yin, Z Wang - BMC medicine, 2023 - Springer
Background The two inactivated SARS-CoV-2 vaccines, CoronaVac and BBIBP-CorV, have
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …

Humoral immune response of BNT162b2 and CoronaVac vaccinations in hemodialysis patients: a multicenter prospective cohort

R Clavero, A Parra-Lucares, G Méndez-Valdés, E Villa… - Vaccines, 2022 - mdpi.com
The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous
data indicate that this vaccine produces a lower immune response than RNA vaccines such …

Effectiveness of vaccination in reducing hospitalization and mortality rates in dialysis patients with Omicron infection in China: A single-center study

Q Zhang, C Lu, H Chen, M Li, X Bai… - Human Vaccines & …, 2023 - Taylor & Francis
The impact of vaccination on the outcomes of dialysis patients with Omicron infections in
China remains unknown. This study aimed to examine the relationship between vaccination …

Survival benefit of a third dose of the COVID-19 vaccine among hemodialysis patients: A prospective cohort study

TH Chen, Y Ho, HL Tai, YC Chu, YP Lin… - Journal of Microbiology …, 2023 - Elsevier
Background Hemodialysis (HD) patients are particularly vulnerable to severe coronavirus
disease 2019 (COVID-19) due to their immunocompromised state and comorbid conditions …

[HTML][HTML] Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients

L Benning, M Bartenschlager, H Kim, C Morath, M Zeier… - Vaccines, 2024 - mdpi.com
We recently showed that an adapted SARS-CoV-2 vaccine with wildtype and BA. 4/BA. 5
Omicron subtype epitopes induced a broad short-term immune response in hemodialysis …

Development of a Peptide Sensor Derived from Human ACE2 for Fluorescence Polarization Assays of the SARS-CoV-2 Receptor Binding Domain

S Okada, Y Muto, B Zhu, H Ueda… - Analytical …, 2023 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the continuing
emergence of infectious variants have caused a serious pandemic and a global economic …

Fatality rate, risk factors, and functional decline in peritoneal dialysis patients with coronavirus disease 2019: A nationwide cohort study

P Chuengsaman, S Boongird, P Dandecha… - Frontiers in …, 2022 - frontiersin.org
Background The fatality rates and factors associated with death from coronavirus disease
2019 (COVID-19) in hemodialysis patients have been extensively investigated. However …

Membranous nephropathy following full-dose of inactivated SARS-CoV-2 virus vaccination: a case report and literature review

T Thammathiwat, L Chompuk, S Worawichawong… - Vaccines, 2022 - mdpi.com
Vaccination against the SARS-CoV-2 virus (COVID-19) has proven to be the most effective
measure to prevent the spread and reduce infection severity. A case report of de novo …

Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines

I Mavrovouniotis, A Fylaktou, M Stagou, K Ouranos… - Life, 2023 - mdpi.com
Simple Summary Patients with end-stage renal disease (ESRD) requiring hemodialysis
(HD) constitute a high-risk group in terms of susceptibility to and severity of infection. High …